Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma. | Blood;81(9): 2263-71, 1993 May 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma.

Grossbard, M L; Gribben, J G; Freedman, A S; Lambert, J M; Kinsella, J; Rabinowe, S N; Eliseo, L; Taylor, J A; Blättler, W A; Epstein, C L.

Affiliation

Grossbard ML; Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.

Blood ; 81(9): 2263-71, 1993 May 01.

Article in En | MEDLINE | ID: mdl-8481509

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ricin / Immunotoxins / Lymphoma, B-Cell / Bone Marrow Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 1993 Document type: Article Country of publication: Estados Unidos

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ricin / Immunotoxins / Lymphoma, B-Cell / Bone Marrow Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 1993 Document type: Article Country of publication: Estados Unidos